These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 28551327)

  • 21. Molecular characterization of V(D)J rearrangements in immature acute leukemias.
    Vianna DT; Reis Monte-Mór BDC; Noronha EP; Gutiyama LM; da Costa ES; Pombo-de-Oliveira MS; Zalcberg I
    Leuk Res; 2024 Aug; 143():107521. PubMed ID: 38879405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    Fukano R; Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Mori T; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kiyokawa N; Kobayashi R; Horibe K; Tsurusawa M
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e34-e37. PubMed ID: 28538509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia].
    Chen LJ; Li JY; Wu YJ; Yang H; Qian SX; Wu HX; Lu H; Xu W; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):692-5. PubMed ID: 17708784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotyping parameters as prognostic factors in T-acute leukemia patients.
    Babusikova O; Stevulova L; Fajtova M
    Neoplasma; 2009; 56(6):508-13. PubMed ID: 19728759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
    Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
    Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
    Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
    Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging Necessity of Myeloid Mutational Analysis in Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL).
    Tariq H; Shetty S
    Turk J Haematol; 2023 Aug; 40(3):227-229. PubMed ID: 37431282
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.
    Han X; Bueso-Ramos CE
    Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.
    Jegalian AG; Bodo J; Hsi ED
    Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
    Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
    J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.
    Zuurbier L; Gutierrez A; Mullighan CG; Canté-Barrett K; Gevaert AO; de Rooi J; Li Y; Smits WK; Buijs-Gladdines JG; Sonneveld E; Look AT; Horstmann M; Pieters R; Meijerink JP
    Haematologica; 2014 Jan; 99(1):94-102. PubMed ID: 23975177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunophenotypic and immunogenotypic analyses of acute leukemia and lymphoblastic lymphoma expressing myeloid and lymphoid antigens].
    Kawamura K; Tobinai K
    Rinsho Byori; 1992 Jul; 40(7):761-8. PubMed ID: 1507495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report.
    Patel JL; Smith LM; Anderson J; Abromowitch M; Campana D; Jacobsen J; Lones MA; Gross TG; Cairo MS; Perkins SL
    Br J Haematol; 2012 Nov; 159(4):454-61. PubMed ID: 22994934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
    La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
    Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion.
    Wang J; Zhang W; Xu X; Buglioni A; Li P; Chen X; Liu Y; Xu M; Herrick JL; Horna P; Zhang X; Song J; Jevremovic D; He R; Shi M; Yuan J
    Hum Pathol; 2024 Sep; 151():105626. PubMed ID: 38971327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.